Our previous studies have demonstrated that breast tumors and tumor cell lines selected for resistance to drugs or isolated from metastatic sites exhibit increased expression of the pro-inflammatory protein tissue transglutaminase [6]–[9]. The gene discussed is TGM2; the disease is neoplasm.